Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll New insights into the pathogenesis of serous ovarian cancer and its clinical impact Levanon K; Crum C; Drapkin RJ Clin Oncol 2008[Nov]; 26 (32): 5284-93There are only a handful of concepts concerning cancer and carcinogenesis that are currently beyond dispute. One such dogma is the adenoma-carcinoma sequence and that a multistep accumulation of genetic alterations is required for transformation from a benign to a neoplastic tissue. The inevitable derivative of this dogma is that every invasive carcinoma is in fact a missed intraepithelial tumor, and furthermore, a late evolutionary stage in the sequence of development from a precursor lesion. Until fairly recently, high-grade serous ovarian carcinoma seemed to be one of the only known deviants of these concepts. In this article, we discuss the emergence of the fallopian tube fimbria as a field of origin for high-grade serous carcinomas and present a binary model of ovarian cancer pathogenesis that takes into consideration prior epidemiologic, morphologic, and genetic data. With the rise of the fallopian tube secretory epithelial cell as a cell of origin for high-grade pelvic serous carcinomas, the need to develop tools and model systems to characterize the biology and physiology of this cell is recognized.|Animals[MESH]|Cell Transformation, Neoplastic/genetics/*pathology[MESH]|Cystadenocarcinoma, Serous/genetics/*pathology/therapy[MESH]|Cystadenoma, Serous/genetics/*pathology/therapy[MESH]|Epithelial Cells/pathology[MESH]|Fallopian Tubes/*pathology[MESH]|Female[MESH]|Gene Expression Regulation, Neoplastic[MESH]|Humans[MESH]|Ovarian Neoplasms/genetics/*pathology/therapy[MESH]|Precancerous Conditions/genetics/*pathology/therapy[MESH] |